Health Department Grant: Advancing Understanding of HDL Function (R01)

This grant opportunity supports projects aiming to enhance knowledge of HDL function by developing assays, biomarkers, and identifying new pathways and targets. Research should focus on innovative methods to assess HDL functional properties like in vivo reverse cholesterol transport and explore novel therapies related to HDL function. The deadline for submission is September 7, 2012.

Opportunity ID: 159533

Apply

General Information

Document Type::	Grants Notice
Funding Opportunity Number::	PA-12-143
Funding Opportunity Title::	Toward an Improved Understanding of HDL Function (R01)
Opportunity Category::	Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity::	Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s)::	93.837 — Cardiovascular Diseases Research
Cost Sharing or Matching Requirement::	No
Version::	Synopsis 1
Posted Date::	Mar 28, 2012
Last Updated Date::
Original Closing Date for Applications::	Sep 07, 2012
Current Closing Date for Applications::	Sep 07, 2012
Archive Date::	Oct 08, 2012
Estimated Total Program Funding::
Award Ceiling::	$
Award Floor::	$

Eligibility

Eligible Applicants::

For profit organizations other than small businesses

Additional Information on Eligibility::

Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name::	National Institutes of Health
Description::	This FOA encourages grant applications that propose to develop, validate, and standardize assays to measure HDL function and biomarkers for HDL function and to identify new pathways and potential HDL targets in the relationship to HDL function. Innovative methods to determine HDL functional properties such as in vivo reverse cholesterol transport (RCT), anti-oxidant, anti-inflammatory, and antithrombotic activities, and biomarkers for HDL function are encouraged. Projects that will explore HDL novel functional pathways and therapeutics related to HDL function are also encouraged.
Link to Additional Information::
Grantor Contact Information::	If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version	Modification Description	Updated Date
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings:	93.837
Competition ID:	ADOBE-FORMS-B2
Competition Title:	ADOBE-FORMS-B2
Opportunity Package ID:	PKG00111890
Opening Date:	May 05, 2012
Closing Date:	Sep 07, 2012
Agency Contact Information::	Grants Info
Who Can Apply::	Organization Applicants
mendatory_forms	SF424 (R & R) [V1.2] Project/Performance Site Location(s) [V1.4] Research And Related Other Project Information [V1.3] Research And Related Senior/Key Person Profile (Expanded) [V1.2] PHS 398 Cover Page Supplement [V1.4] PHS 398 Research Plan [V1.3] PHS 398 Checklist [V1.3]
optional_forms	R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.2] PHS 398 Modular Budget [V1.2] Research & Related Budget [V1.1] PHS Cover Letter [V1.2]